Wockhardt - A story with twist and turn

[Gaurav_Agarwal]

Confirming my earlier estimates Mr. Khorakiwala said that Nifithromycin could be 500-700cr drug in Indian market in 2-3 years.

Also, Phase III clinical trail of WCK-5222 is complete.

Expect 65-70% Market Share Over The Next 4-5 Years For Miqnaf Drug: Wockhardt | CNBC TV18